Skip to main content
. 2016 May 23;60(6):3759–3766. doi: 10.1128/AAC.00391-16

TABLE 2.

In vitro and in vivo daily release rates and in vitro-in vivo correlation

Drug (IVR formulation)a Release rate (mg day−1)b
IVIVCc
In vitro In vivo
TDF 0.88 ± 0.04 0.31 ± 0.13 0.35
MVC 2.72 ± 0.08 0.67 ± 0.19 0.25
a

n = 4.

b

Data represent means ± SD.

c

IVIVC, in vitro-in vivo correlation; defined as in vivo release rate divided by in vitro release rate.

HHS Vulnerability Disclosure